Margaret Wooddell PhD, M., PhD, D. D., PhD, F. L., MS, I. P., PhD, K. F., PhD, X. Y., . . . MD, W. D. T. Patient-Reported Continued Benefits in Patients Treated with Pexidartinib for Tenosynovial Giant Cell Tumor Based on a Real-World Study in the United States. SAGE Publishing.
Chicago Style (17th ed.) CitationMargaret Wooddell PhD, MBA, Dong Dai PhD, Feng Lin PhD, Irene Pan MS, Klaus Freivogel PhD, Xin Ye PhD, Kristen Tecson PhD, and William D. Tap MD. Patient-Reported Continued Benefits in Patients Treated with Pexidartinib for Tenosynovial Giant Cell Tumor Based on a Real-World Study in the United States. SAGE Publishing.
MLA (9th ed.) CitationMargaret Wooddell PhD, MBA, et al. Patient-Reported Continued Benefits in Patients Treated with Pexidartinib for Tenosynovial Giant Cell Tumor Based on a Real-World Study in the United States. SAGE Publishing.